These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33942928)

  • 41. Incidence rates of viral infections among repeat donors:are frequent donors safer?
    Schreiber GB; Glynn SA; Busch MP; Sharma UK; Wright DJ; Kleinman SH;
    Transfusion; 2001 Jun; 41(6):730-5. PubMed ID: 11399811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
    Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
    Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
    Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
    Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regular plateletpheresis increased basal concentrations of soluble P-selectin in healthy donors: Possible involvement of endothelial cell activation?
    Chen Y; Lin Y; Lin H; Xiao J; Jiang L; Chen C; Zhuo X; Huang W; Zeng J; Dettke M
    Clin Chim Acta; 2016 Jul; 458():18-22. PubMed ID: 27108199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!
    Kaur S; Mittal K; Kaur R; Kaur G; Kaur P; Sood T
    Transfus Clin Biol; 2022 May; 29(2):141-146. PubMed ID: 34856397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Status of platelet collection and platelet transfusion.
    Omokawa S; Notoya T; Kumagai M; Takada G; Watanabe E; Echigoya Y; Saito M; Abe M; Osato N; Kawakami K
    Ther Apher; 2001 Feb; 5(1):17-21. PubMed ID: 11258603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor retention as a function of donor reactions to whole-blood and automated double red cell collections.
    Rader AW; France CR; Carlson B
    Transfusion; 2007 Jun; 47(6):995-1001. PubMed ID: 17524088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum ferritin in plateletpheresis and whole blood donors.
    Duggan F; O'Sullivan K; Power JP; Healy M; Murphy WG
    Transfus Apher Sci; 2016 Aug; 55(1):159-63. PubMed ID: 27339300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
    Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
    Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Double RBC Collection by Blood Cell Separators.
    Kitpoka P; Chanthet S; Chongkolwatana V; Chuansumrit A; Kunakorn M
    J Med Assoc Thai; 2016 Jan; 99(1):88-96. PubMed ID: 27455830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects on donors of repeated leukocyte losses during plateletpheresis.
    Strauss RG
    J Clin Apher; 1994; 9(2):130-4. PubMed ID: 7798161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The infectious disease blood safety risk of Australian hemochromatosis donations.
    Hoad V; Bentley P; Bell B; Pathak P; Chan HT; Keller A
    Transfusion; 2016 Dec; 56(12):2934-2940. PubMed ID: 27662424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative experiences and donor return: an examination of the role of asking for something different.
    Masser BM; Bove LL; White KM; Bagot KL
    Transfusion; 2016 Mar; 56(3):605-13. PubMed ID: 26472686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat whole-blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs.
    Glynn SA; Smith JW; Schreiber GB; Kleinman SH; Nass CC; Bethel J; Biswas B; Thomson RA; Williams AE;
    Transfusion; 2001 Jun; 41(6):736-43. PubMed ID: 11399812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Chinese donors' return behavior.
    Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Wright DJ; King M; High P; Nelson K; Shan H;
    Transfusion; 2011 Mar; 51(3):523-30. PubMed ID: 20849408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.